Table 6.
Trial subject area | Number | Percentage |
---|---|---|
Oncology/haematology – cancer | 161 | 21 |
Neurology – neurodegenerative diseases, vascular diseases | 77 | 10 |
Cardiology – cardiovascular disease | 62 | 8 |
Orthopaedics/musculoskeletal | 56 | 7 |
Mental health | 51 | 7 |
Metabolism – diabetes mellitus | 47 | 6 |
Vaccines – preventive vaccines | 45 | 6 |
Reproductive health | 33 | 4 |
Critical care | 24 | 3 |
Infectious diseases | 21 | 3 |
Gastroenterology – hepatology, nephrology | 18 | 2 |
Surgery | 16 | 2 |
Respiratory | 15 | 2 |
Paediatrics/neonates | 13 | 2 |
Inflammatory conditions (e.g. osteoarthritis, rheumatoid arthritis, fibromyalgia) | 11 | 1 |
Ophthalmology | 9 | 1 |
Involved in multiple trials | 34 | 4 |
Other | 82 | 11 |
Totala | 785 | 96 |
aData missing in 30 respondents